Search

Your search keyword '"Sadegh Jafarnejad"' showing total 2 results
Start Over Author "Sadegh Jafarnejad" Journal bmc cardiovascular disorders
2 results on '"Sadegh Jafarnejad"'

1. The hypotensive effect of salt substitutes in stage 2 hypertension: a systematic review and meta-analysis

Author

Sadegh Jafarnejad, Hamed Mirzaei, Cain C. T. Clark, Mohsen Taghizadeh, and Armin Ebrahimzadeh

Subjects
Hypertension, Salt substitutes, Systolic blood pressure, Diastolic blood pressure, Meta-analysis, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Abstract Background Hypertension (HTN) is a ubiquitous risk factor for numerous non-communicable diseases, including cardiovascular disease and stroke. There are currently no wholly effective pharmacological therapies for subjects with HTN. However, salt substitutes have emerged as a potential therapy for the treatment of HTN. The aim of the present study was to assess the effect of salt substitutes on reducing systolic blood pressure (SBP) and diastolic BP (DBP), following a meta-analysis of randomized controlled trials. Methods Studies were found via systematic searches of the Pubmed/Medline, Scopus, Ovid, Google Scholar and Cochrane library. Ten studies, comprised of 11 trials and 1119 participants, were included in the meta-analysis. Results Pooled weighted mean differences showed significant reductions of SBP (WMD − 8.87 mmHg; 95% CI − 11.19, − 6.55, p

Published
2020
Full Text
View/download PDF

2. The hypotensive effect of salt substitutes in stage 2 hypertension: a systematic review and meta-analysis

Author

Mohsen Taghizadeh, Cain C T Clark, Sadegh Jafarnejad, Armin Ebrahimzadeh, and Hamed Mirzaei

Subjects
Adult, Male, lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.medical_specialty, MEDLINE, Blood Pressure, 030204 cardiovascular system & hematology, Cochrane Library, Risk Assessment, law.invention, Salt substitutes, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Risk Factors, law, Diastolic blood pressure, Internal medicine, medicine, Humans, cardiovascular diseases, 030212 general & internal medicine, Sodium Chloride, Dietary, Risk factor, Stroke, Aged, Randomized Controlled Trials as Topic, Angiology, business.industry, Diet, Sodium-Restricted, Middle Aged, Protective Factors, medicine.disease, Meta-analysis, Treatment Outcome, Blood pressure, lcsh:RC666-701, Hypertension, Systolic blood pressure, Female, Diet, Healthy, Cardiology and Cardiovascular Medicine, business, Risk Reduction Behavior, Research Article
Abstract

Background Hypertension (HTN) is a ubiquitous risk factor for numerous non-communicable diseases, including cardiovascular disease and stroke. There are currently no wholly effective pharmacological therapies for subjects with HTN. However, salt substitutes have emerged as a potential therapy for the treatment of HTN. The aim of the present study was to assess the effect of salt substitutes on reducing systolic blood pressure (SBP) and diastolic BP (DBP), following a meta-analysis of randomized controlled trials. Methods Studies were found via systematic searches of the Pubmed/Medline, Scopus, Ovid, Google Scholar and Cochrane library. Ten studies, comprised of 11 trials and 1119 participants, were included in the meta-analysis. Results Pooled weighted mean differences showed significant reductions of SBP (WMD − 8.87 mmHg; 95% CI − 11.19, − 6.55, p Conclusions These findings suggest that salt-substitution strategies could be used for lowering SBP and DBP in patients with stage 2 HTN; providing a nutritional platform for the treatment, amelioration, and prevention of HTN.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results